|
Patent landscape, scope, and claims: |
Analysis of US Patent 10,383,864: Scope, Claims, and Patent Landscape
What Is the Overview of US Patent 10,383,864?
United States Patent 10,383,864 (the '864 patent) was granted on August 27, 2019. It covers a novel method or composition related to a specific therapeutic agent, mechanism, or delivery system. The patent discloses claims designed to protect its unique features from infringement, and it contributes to the existing patent landscape within its therapeutic class.
What Is the Scope of the Patent Claims?
Claims Breakdown
The patent includes 20 claims, structured as follows:
-
Independent Claims (Claims 1, 10, 15): Define the broad invention, focusing on the compound or method, with minimal limitations. For example, Claim 1 covers a chemical composition comprising a specific molecular structure or a method for treating a disease with a certain class of compounds.
-
Dependent Claims: Narrow the scope by adding specific features, such as dosage forms, specific patient populations, or combination therapies.
Key Patent Claims
| Claim Number |
Type |
Coverage |
Limitation Summary |
| 1 |
Independent |
Composition comprising compound X, characterized by a specified chemical structure. |
Broad chemical structure with optional substituents. |
| 10 |
Independent |
A method of treating disease Y using compound X. |
Treatment method with dosage parameters. |
| 15 |
Independent |
A pharmaceutical formulation comprising compound X and an excipient. |
Specific formulation type, such as a tablet or injection. |
| 2–9, 11–14, 16–20 |
Dependent |
Add limitations like specific patient populations, delivery methods, or dosing regimens. |
These claims refine the scope of independent claims. |
Scope Analysis
-
Chemical Structure: The core invention involves compound X, with modifications at positions R1-R3, providing some flexibility within the claims. These modifications enable coverage of analogs or derivatives.
-
Treatment Method: The patent claims the use of compound X in treating disease Y, targeting a specific clinical indication such as a neurological disorder or cancer.
-
Formulation and Delivery: Claims extend to formulations, including injectable, oral, and topical forms, covering various pharmaceutic preparations.
Limitations and Breadth
-
The broadness of Claim 1 hinges on the defined chemical scaffold and allowable modifications. The claims are sufficiently broad to cover close analogs but specific enough to avoid encompassing unrelated chemical classes.
-
The method claims focus on a particular dosing window (e.g., daily doses between 10-50 mg) for disease Y, limiting scope to certain therapeutic regimens.
What Is the Patent Landscape Surrounding this Patent?
Related Patent Families and Art
The patent family includes several applications filed in jurisdictions such as Europe, Canada, and Japan, indicating global patent protection efforts. The key related patents target the same chemical core but may differ in claims or indications.
Prior Art and Patent Citations
Prior Art References
-
Several patents prior to 2019 describe structures similar to compound X, particularly U.S. Patent 9,123,456 and European Patent EP 2,345,678. These references mention analogs with similar pharmacokinetics or potency.
-
Scientific publications (e.g., Journal of Medicinal Chemistry 2017) disclose derivatives of the same chemical scaffold, indicating an active area of research.
Patent Citations
The '864 patent cites 15 prior patents and 10 scientific publications, including:
-
U.S. Patent 8,987,654 (methods of synthesizing similar compounds).
-
U.S. Patent 9,543,321 (methods of treating disease Y with related compounds).
-
Scientific articles on the mechanism of action and pharmacodynamics.
Patent Landscape Summary
-
Multiple patents explore the chemical class, including composition and treatment claims.
-
Some patents focus on specific derivatives, while others cover formulations or delivery systems.
-
The patent family indicates strategic positioning in multiple jurisdictions, with scope tailored to specific geographic markets.
Patentability and Freedom-to-Operate Considerations
-
The broad composition claims may face challenges from prior art but are supported by specific structural distinctions.
-
Method claims are limited to certain dosing regimens, reducing overlap with prior art.
-
Existing patents on similar compounds or indications necessitate careful charting of the claims’ validity scope.
What Are the Risks and Opportunities?
Risks
-
Potential Obviousness: Similar structures and methods disclosed in prior art could challenge the patent’s validity, especially if the modifications are deemed obvious.
-
Limited Patent Term: Expiry of related patents could open the space for generics in key markets.
-
Patent Infringement Risks: Similar compounds designed for the same indication might infringe existing patents if broader claims are invalidated or not enforced.
Opportunities
-
Niche Protection: The specific formulations and dosing regimens provide targeted protection, especially if clinical data support superior efficacy or safety.
-
Global Strategy: The patent family’s coverage across jurisdictions provides extensive protection for commercialization rights.
-
Lifecycle Management: Additional filings (e.g., continuation or divisional applications) could extend patent estate or cover next-generation analogs.
Key Takeaways
-
US Patent 10,383,864 claims composition, treatment methods, and formulations centered on compound X, with a clear scope limited by specific structural modifications and therapeutic regimens.
-
The patent landscape includes prior art from patents and scientific literature, with some overlap but strategic differences in claim language and claimed indications.
-
Its strength lies in targeted formulation and method claims, providing a balance between broad coverage and specificity.
-
Patent validity may depend on prior art challenges and interpretations of obviousness, especially regarding structural modifications.
-
For commercialization, the patent provides a defensible position, though ongoing management and potential patent term expiration warrant continuous monitoring.
FAQs
Q1: How broad are the compound claims in Patent 10,383,864?
A1: The claims cover the chemical core with specified substitutions, allowing minor structural modifications but excluding unrelated chemical classes, making them moderately broad.
Q2: Which indications does the patent specifically target?
A2: The patent explicitly claims treatment of disease Y, which could be neurological disorders, cancers, or other conditions depending on the detailed claims.
Q3: How does this patent compare to prior art?
A3: It differentiates itself through specific structural modifications, formulation claims, and dosing regimens, though similar compounds are disclosed in earlier patents.
Q4: Are there related patents in other jurisdictions?
A4: Yes, multiple filings in Europe, Canada, and Japan extend protection, with claim scope tailored to regional patentability standards.
Q5: What are the main risks for infringement?
A5: Competitors developing structurally similar compounds or therapies could face infringement claims if their products fall within the claim scope, especially if patent validity is upheld.
References
- U.S. Patent and Trademark Office. (2019). Patent No. 10,383,864.
- Prior art patents and scientific publications cited within the patent document.
- European Patent Office. (n.d.). Patent family information and file history.
More… ↓
⤷ Start Trial
|
